H

Henry Schein

Global healthcare product distributor and services

Finance Manager - JV

Full-TimeUpdated on 10/23/2026
No salary listed
Expert
Bachelor's
Wuhan, Hubei, China
In PersonBased in Wuhan; onsite.
Finance & BankingCorporate Finance & FP&A

About the job

Requirements
  • At least 10 years of experience in a senior accounting or finance role, with a proven track record of achievements.
  • A bachelor's degree in finance, accounting, business, or a relevant major.
  • Excellent computer skills in Excel and Word.
  • Knowledge of ERP processes and overall concepts.
  • Finance-model ERP skills.
  • Ability to work cooperatively, especially with management.
  • High attention to compliance guidelines.
  • Strong sense of risk control.
  • Ability to deliver results by deadlines.
  • Structured and logical thinking.
Responsibilities
  • Provide support to the local management team, local sales and marketing for business support, and local operations for policy implementation.
  • Prepare monthly reporting under PRC and US GAAP within the specified monthly timeframe.
  • Organize monthly, quarterly, and annual closing and balance sheet reconciliations to ensure accurate and timely bookkeeping.
  • Monitor VAT invoice reports and reconcile them with purchases and sales at month end.
  • Prepare monthly, quarterly, and annual tax returns, including VAT and income tax.
  • Work with external auditors on the annual audit.
  • Work with operations on the annual physical count.
  • Monitor customer credit information and conduct credit control for daily business.
  • Work with the operations team to safeguard inventory, including regular and consignment stock checks.
  • Review implementation of the internal control system, including ICIS and China group policies.
  • Conduct quarterly sampling and testing of SOX controls and document evidence for review.
  • Identify and analyze risks and report exceptional cases to senior management when necessary.
  • Prepare statutory reports for local authorities and external stakeholders.
  • Assist in preparing group reports, including financial and non-financial information.
  • Prepare monthly reports for group and local management within the agreed timeframe.
  • Provide information to the JV Finance Controller for group reporting.
  • Review FCPA payment applications and monitor compliance.
  • Prepare the local monthly business review deck.
  • Develop performance measures to support the company's healthy growth.
  • Prepare ad hoc analyses as required.
  • Prepare the company budget and monitor and control it.
  • Liaise with business units to prepare monthly financial forecasts.
  • Support the Managing Director with financial analysis for investment decisions.
  • Monitor productivity levels in operations.
  • Support the Managing Director in supplier negotiations and assist with managing gross profit margins.
  • Prepare monthly cash flow forecasts for the company.
  • Work with the JV Finance Controller on working capital management and treasury requirements.
  • Act as a business partner to the Managing Director and participate in regular business, budget, and forecast reviews with the wider Henry Schein Group.
Desired Qualifications
  • Experience working at one of the top four audit firms at the start of the candidate's career may be relevant.

About the company

Henry Schein is a global supplier of healthcare products and services. It operates in two segments: healthcare distribution, which provides dental and medical consumables, equipment, and laboratory products to dentists, physicians, and veterinarians; and technology and value-added services, which offers practice management software, e-commerce solutions, and financial services. The company works by supplying healthcare professionals with a broad range of products and by offering software, online tools, and financing options to run their practices more efficiently. Compared with competitors, Henry Schein combines a wide product catalog with software and financial services, creating a one-stop platform for practice needs across more than 30 countries, with a strong focus on North America. Its goal is to be a trusted partner for healthcare professionals by supporting their day-to-day operations and growth through integrated distribution, technology, and financing solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Town of Huntington, New York

Founded

1932

Get referred to Henry Schein

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 sales reached $3.5 billion, and management raised full-year guidance.
  • Dentrix Ascend installs tripled since January 2025, with June's record new-customer month.
  • The $1.25 billion credit facility extends to September 19, 2031, funding buybacks and acquisitions.

What critics are saying

  • July 30, 2026 leadership restructuring exits three executives on October 30, 2026.
  • Henry Schein One faces Maryland and Utah lawsuits with filings continuing September 2026.
  • Q2 2026 restructuring expense hit $29 million; repeated charges pressure GAAP earnings.

What makes Henry Schein unique

  • Henry Schein One serves 90% of top 50 DSOs with recurring, high-margin software.
  • One Schein bundles distribution, exclusive brands like Curodont, and practice software.
  • Camlog, Biotech Dental, and Edge strengthen proprietary pricing against commodity distributors.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Company Match
  • Paid Vacation
  • Paid Parental Leave
  • Short Term Disability
  • Health Savings Account/Flexible Spending Account
  • Education Benefits

Growth & Insights and Company News

6 month growth

7%

1 year growth

7%

2 year growth

7%
Yahoo Finance
Sep 30th, 2026
Henry Schein Cares celebrates 25 years with $285M in donations and product contributions

Henry Schein Cares, the corporate citizenship programme of Henry Schein, Inc., is celebrating its 25th anniversary. Since its launch in 2001, the programme has contributed more than $285 million in cash and donated products whilst collaborating with over 5,000 charitable partners worldwide. The programme operates through five pillars: catalysing healthcare access, advancing policies and solutions, relationship building, empowering Team Schein, and sustaining the planet. Key initiatives include supporting the American Dental Association Foundation's Give Kids A Smile programme, which has helped more than 10.2 million underserved children receive oral health services since 2003. Henry Schein celebrated the milestone during UN General Assembly Week in New York City. The company is advancing towards its Net Zero 2050 goal and aims to source 100% renewable energy by 2030.

TipRanks
Sep 22nd, 2026
Henry Schein expands credit facility to $1.25B, extends term to 2031

Henry Schein has amended and restated its revolving credit agreement, expanding aggregate commitments from $1 billion to $1.25 billion. The facility's termination date has been extended to 19 September 2031. The revised facility, arranged with a syndicate of major international banks, adjusts certain financial definitions and covenants. This provides the healthcare distribution company with greater flexibility in its capital structure. Henry Schein intends to use the enlarged credit facility for working capital and general corporate purposes. These include capital expenditures, share repurchases, refinancing existing debt, and funding potential acquisitions. The agreement includes customary representations, warranties, covenants, and events of default. The company supplies dental, medical, and animal health products to office-based practitioners and healthcare organisations in North America and international markets.

Yahoo Finance
Aug 31st, 2026
Henry Schein shares up 13% in Q2 as cost cuts and revenue growth support bullish outlook

MD Sass Concentrated Value Strategy highlighted Henry Schein as a notable contributor in its second-quarter 2026 investor letter. The healthcare solutions provider saw its shares appreciate 13% during the quarter. The asset management firm believes significant cost reductions combined with accelerating revenue growth should lead to material positive earnings revisions moving into the fourth quarter and 2027. MD Sass met with Henry Schein's new chief executive officer, Fred Lowery, and expects his distribution experience and operational approach to improve efficiencies, margins, and market share. The firm's estimates remain well above consensus over the next several years. Henry Schein closed at $89.52 per share on 28 August 2026, with a market capitalisation of $9.98 billion.

Yahoo Finance
Aug 13th, 2026
Henry Schein beats Q2 estimates with $3.46B revenue, raises full-year guidance on dental growth

Henry Schein reported second-quarter results that exceeded Wall Street expectations, with revenue of $3.46 billion versus analyst estimates of $3.37 billion and adjusted EPS of $1.27 versus $1.24 expected. The company attributed the performance to accelerating internal sales growth and robust gains in its global dental merchandise segment. CEO Frederick Lowery highlighted success in converting occasional buyers into regular customers and strong market share gains in the US and Canada. The company slightly raised its full-year adjusted EPS guidance to $5.34 at the midpoint. During the earnings call, analysts questioned the sustainability of US dental consumables growth and the timing of value creation benefits. CFO Ronald South indicated most operating income improvements from these initiatives would materialise in the second half of the year.

Yahoo Finance
Aug 4th, 2026
Henry Schein raises 2026 guidance after Q2 sales hit $3.5B on dental gains

Henry Schein reported second-quarter sales of $3.5 billion, up 6.7% year-over-year, driven by 4.6% internal local-currency growth and foreign exchange benefits. The healthcare distributor raised its full-year guidance following stronger-than-expected performance. GAAP net income rose to $94 million, or $0.82 per diluted share, from $86 million a year earlier. Non-GAAP earnings reached $1.27 per share, up 15.5% from $1.10 in the prior-year period. Operating margins expanded across all segments. GAAP operating margin increased 27 basis points to 4.94%, whilst non-GAAP operating margin grew 25 basis points to 7.21%. US dental merchandise sales climbed 8.3%, including 6.5% internal growth, with the company reporting market-share gains. Chief Executive Officer Fred Lowery attributed results to operational execution and early benefits from its value-creation programme.